AGILE: PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF IVOSIDENIB IN COMBINATION WITH AZACITIDINE IN ADULTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA AND AN IDH1 MUTATION
EHA Library, Pau Montesinos,
297778
FRONTLINE TREATMENT WITH VENETOCLAX, POSACONAZOLE, AND STANDARD DOSE CYTARABINE OR AZACITIDINE FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
EHA Library, Tran-Der Tan,
297786